Page All:
Page 1
Elsevier Upgrades illumin8, Enhancing Access to Critical Information at the Front End of Innovation
NEW YORK, July 27, 2011/PRNewswire-FirstCall/ --
Web-based research tool provides innovative new features for helping
researchers explore new technologies, product applications and markets
Elsevier, the world's leading provider of scientific, technical and
medical information products and services today announced the expansion of
illumin8 [http://www.illumin8.com ], its groundbreaking semantic search tool
first launched in 2008. illumin8, which indexes scientific, patent, news and
web content from Elsevier and other trusted sources, now offers a range of
new features. These include an improved ability to explore technology trends
and white space opportunities, evaluate potential new technologies and
product applications, and compare organizations, products, people and
approaches.
"The early stage of the innovation process is often referred to as the
fuzzy front-end. At this point in our customers' workflow, using regular
search can feel like reaching around in the dark, especially when they are
dealing with unfamiliar markets or emerging technologies or products," said
Robbertjan Kalff, VP for Product Development for Engineering and Technology
and Alternative Energy at Elsevier. "Users say that this is the time where
they don't know what they don't know, but at the same time they need a way
to get on the right track faster. This is the need that illumin8 addresses."
The functionality of illumin8 is further enhanced by the introduction of
illumin8 Reports [http://www.illumin8.com/report.html ]-- customizable
documents that users can create to share their findings and analysis of a
research topic. The new functionality was developed based on customer
requests and testing with a representative group drawn from the thousands of
illumin8 users worldwide -- including innovation leaders and R&D scientists
and engineers from leading Fortune 500 companies. illumin8 customers come
from across industries such as Automotive, Chemicals, and Consumer Packaged
Goods, and the web-based tool has been enhanced to closely align with its
users' workflow and the questions they need to answer at the front-end of
innovation.
illumin8 supports an organization's innovation platform by helping
identify new technologies and applications for product development,
supporting risk assessment of entering new market space, uncovering
competitor activity and helping identify potential new partners or
suppliers. Unlike regular search platforms, illumin8 is able to easily
identify and show relationships between concepts and entities such as
technologies, organizations, products, and scientific approaches-which is
often buried in document text and could take many hours or weeks to capture
and assess.
This latest upgrade allows R&D and innovation professionals to quickly
access high quality information, uniquely formatting it to their
requirements:
- Explore - provides a quick overview of the organizations,
products, people and approaches related to a technology or other topic,
allowing users to quickly grasp the 'who and what' of a market space.
- Evaluate -supports investigation of the related benefits and
applications of a technology, process or product. Potential risks and
problems are uncovered, which can help speed the product development
process and uncover opportunities to fill a potential gap in the market
- Compare -generates side by side views of two organizations,
potential partners or products to support the evaluation of current or
potential competitors or to help identify possible partners
- Report -illumin8 Reports allow users to summarize their analysis
of a new technology, product application, competitor or unfamiliar
market space, build shortlists with notes for assessing potential
partners, suppliers, and experts, highlight the most relevant results
and records from scientific journals, patents, news and web sources and
output all their findings in a customizable document.
illumin8 has become a vital part of the R&D process for those on the
cutting edge of innovation. The introduction of these four new features will
help further enable users to quickly discover and share new information at
the front end, which in turn informs and speeds up product and partnering
decisions.
About illumin8
illumin8 is a web-based research tool that enables more confident
product and partnering decisions at the front-end of innovation. Beyond just
search results, illumin8 leverages semantic search technology to uncover
hidden insights and relationships between technologies, organizations,
products, and scientific approaches. It indexes a content base of 40
million+ scientific records from Elsevier and 5,000+ publishers, 24 million+
patents from 5 patent offices worldwide, and billions of web pages that
include 1,000+ online business, technical and news sources. For further
product information, please visit http://www.illumin8.com
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Tom Reller
VP, Global Corporate Relations, Elsevier
t.reller@elsevier.com
+1-215-239-3508
Source: Elsevier
.
Elsevier Upgrades illumin8, Enhancing Access to Critical Information at the Front End of Innovation
NEW YORK, July 27, 2011/PRNewswire-FirstCall/ --
Web-based research tool provides innovative new features for helping
researchers explore new technologies, product applications and markets
Elsevier, the world's leading provider of scientific, technical and
medical information products and services today announced the expansion of
illumin8 [http://www.illumin8.com ], its groundbreaking semantic search tool
first launched in 2008. illumin8, which indexes scientific, patent, news and
web content from Elsevier and other trusted sources, now offers a range of
new features. These include an improved ability to explore technology trends
and white space opportunities, evaluate potential new technologies and
product applications, and compare organizations, products, people and
approaches.
"The early stage of the innovation process is often referred to as the
fuzzy front-end. At this point in our customers' workflow, using regular
search can feel like reaching around in the dark, especially when they are
dealing with unfamiliar markets or emerging technologies or products," said
Robbertjan Kalff, VP for Product Development for Engineering and Technology
and Alternative Energy at Elsevier. "Users say that this is the time where
they don't know what they don't know, but at the same time they need a way
to get on the right track faster. This is the need that illumin8 addresses."
The functionality of illumin8 is further enhanced by the introduction of
illumin8 Reports [http://www.illumin8.com/report.html ]-- customizable
documents that users can create to share their findings and analysis of a
research topic. The new functionality was developed based on customer
requests and testing with a representative group drawn from the thousands of
illumin8 users worldwide -- including innovation leaders and R&D scientists
and engineers from leading Fortune 500 companies. illumin8 customers come
from across industries such as Automotive, Chemicals, and Consumer Packaged
Goods, and the web-based tool has been enhanced to closely align with its
users' workflow and the questions they need to answer at the front-end of
innovation.
illumin8 supports an organization's innovation platform by helping
identify new technologies and applications for product development,
supporting risk assessment of entering new market space, uncovering
competitor activity and helping identify potential new partners or
suppliers. Unlike regular search platforms, illumin8 is able to easily
identify and show relationships between concepts and entities such as
technologies, organizations, products, and scientific approaches-which is
often buried in document text and could take many hours or weeks to capture
and assess.
This latest upgrade allows R&D and innovation professionals to quickly
access high quality information, uniquely formatting it to their
requirements:
- Explore - provides a quick overview of the organizations,
products, people and approaches related to a technology or other topic,
allowing users to quickly grasp the 'who and what' of a market space.
- Evaluate -supports investigation of the related benefits and
applications of a technology, process or product. Potential risks and
problems are uncovered, which can help speed the product development
process and uncover opportunities to fill a potential gap in the market
- Compare -generates side by side views of two organizations,
potential partners or products to support the evaluation of current or
potential competitors or to help identify possible partners
- Report -illumin8 Reports allow users to summarize their analysis
of a new technology, product application, competitor or unfamiliar
market space, build shortlists with notes for assessing potential
partners, suppliers, and experts, highlight the most relevant results
and records from scientific journals, patents, news and web sources and
output all their findings in a customizable document.
illumin8 has become a vital part of the R&D process for those on the
cutting edge of innovation. The introduction of these four new features will
help further enable users to quickly discover and share new information at
the front end, which in turn informs and speeds up product and partnering
decisions.
About illumin8
illumin8 is a web-based research tool that enables more confident
product and partnering decisions at the front-end of innovation. Beyond just
search results, illumin8 leverages semantic search technology to uncover
hidden insights and relationships between technologies, organizations,
products, and scientific approaches. It indexes a content base of 40
million+ scientific records from Elsevier and 5,000+ publishers, 24 million+
patents from 5 patent offices worldwide, and billions of web pages that
include 1,000+ online business, technical and news sources. For further
product information, please visit http://www.illumin8.com
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Tom Reller
VP, Global Corporate Relations, Elsevier
t.reller@elsevier.com
+1-215-239-3508
Source: Elsevier
.